�ݺ�ߣshows by User: ThalassaemiaInternat

�ݺ�ߣshows by User: ThalassaemiaInternat / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: ThalassaemiaInternat / Fri, 05 Aug 2022 06:57:03 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: ThalassaemiaInternat Short Guide For the Management of Transfusion-Dependent Thalassaemia (2nd Edition - 2022) /ThalassaemiaInternat/short-guide-for-the-management-of-transfusiondependent-thalassaemia-2nd-edition-2022 tdt-guide-2022-for-web-220805065703-248e232b
By providing a short pocket guide describing the best possible practices in the treatment and management of transfusion-dependent thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients with the disorder and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. The 4th edition of the original full-length Guidelines, published in June 2022, includes a full review of the evidence supporting almost each recommendation for physicians to know all the facts that form the basis of their clinical decisions in the form of a long textbook, difficult to use on a daily basis.]]>
By providing a short pocket guide describing the best possible practices in the treatment and management of transfusion-dependent thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients with the disorder and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. The 4th edition of the original full-length Guidelines, published in June 2022, includes a full review of the evidence supporting almost each recommendation for physicians to know all the facts that form the basis of their clinical decisions in the form of a long textbook, difficult to use on a daily basis.]]> Fri, 05 Aug 2022 06:57:03 GMT /ThalassaemiaInternat/short-guide-for-the-management-of-transfusiondependent-thalassaemia-2nd-edition-2022 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Short Guide For the Management of Transfusion-Dependent Thalassaemia (2nd Edition - 2022) ThalassaemiaInternat By providing a short pocket guide describing the best possible practices in the treatment and management of transfusion-dependent thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients with the disorder and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. The 4th edition of the original full-length Guidelines, published in June 2022, includes a full review of the evidence supporting almost each recommendation for physicians to know all the facts that form the basis of their clinical decisions in the form of a long textbook, difficult to use on a daily basis. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tdt-guide-2022-for-web-220805065703-248e232b-thumbnail.jpg?width=120&height=120&fit=bounds" /> By providing a short pocket guide describing the best possible practices in the treatment and management of transfusion-dependent thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients with the disorder and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. The 4th edition of the original full-length Guidelines, published in June 2022, includes a full review of the evidence supporting almost each recommendation for physicians to know all the facts that form the basis of their clinical decisions in the form of a long textbook, difficult to use on a daily basis.

Short Guide For the Management of Transfusion-Dependent Thalassaemia (2nd Edition - 2022) from Thalassaemia International Federation

]]> 67 0 https://cdn.slidesharecdn.com/ss_thumbnails/tdt-guide-2022-for-web-220805065703-248e232b-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Basic Recommendations in Brief for Treating Physicians (2022) /slideshow/basic-recommendations-in-brief-for-treating-physicians-2022/252436895 enrecommendationsforhealthcareprofessionals1-220805065208-e2a09f46
The ‘Basic Recommendations in Brief for Treating Physicians’, based on and complementing the ‘Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021)’, is an easy-to-understand, user-friendly resource for thalassaemia-treating clinicians, especially for those who are not fully experienced and well-knowledgeable of the management of patients with this serious chronic disorder, or those operating in Urgent and Emergency Care (UEC) settings admitting haemoglobinopathy patients. These key recommendations offer valuable guidance on a variety of thematics pertaining to thalassaemia management, ranging from blood transfusion and iron overload and chelation to the assessment of cardiovascular and liver disease, pregnancy management, and much more.]]>
The ‘Basic Recommendations in Brief for Treating Physicians’, based on and complementing the ‘Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021)’, is an easy-to-understand, user-friendly resource for thalassaemia-treating clinicians, especially for those who are not fully experienced and well-knowledgeable of the management of patients with this serious chronic disorder, or those operating in Urgent and Emergency Care (UEC) settings admitting haemoglobinopathy patients. These key recommendations offer valuable guidance on a variety of thematics pertaining to thalassaemia management, ranging from blood transfusion and iron overload and chelation to the assessment of cardiovascular and liver disease, pregnancy management, and much more.]]> Fri, 05 Aug 2022 06:52:08 GMT /slideshow/basic-recommendations-in-brief-for-treating-physicians-2022/252436895 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Basic Recommendations in Brief for Treating Physicians (2022) ThalassaemiaInternat The ‘Basic Recommendations in Brief for Treating Physicians’, based on and complementing the ‘Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021)’, is an easy-to-understand, user-friendly resource for thalassaemia-treating clinicians, especially for those who are not fully experienced and well-knowledgeable of the management of patients with this serious chronic disorder, or those operating in Urgent and Emergency Care (UEC) settings admitting haemoglobinopathy patients. These key recommendations offer valuable guidance on a variety of thematics pertaining to thalassaemia management, ranging from blood transfusion and iron overload and chelation to the assessment of cardiovascular and liver disease, pregnancy management, and much more. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/enrecommendationsforhealthcareprofessionals1-220805065208-e2a09f46-thumbnail.jpg?width=120&height=120&fit=bounds" /> The ‘Basic Recommendations in Brief for Treating Physicians’, based on and complementing the ‘Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021)’, is an easy-to-understand, user-friendly resource for thalassaemia-treating clinicians, especially for those who are not fully experienced and well-knowledgeable of the management of patients with this serious chronic disorder, or those operating in Urgent and Emergency Care (UEC) settings admitting haemoglobinopathy patients. These key recommendations offer valuable guidance on a variety of thematics pertaining to thalassaemia management, ranging from blood transfusion and iron overload and chelation to the assessment of cardiovascular and liver disease, pregnancy management, and much more.

Basic Recommendations in Brief for Treating Physicians (2022) from Thalassaemia International Federation

]]> 48 0 https://cdn.slidesharecdn.com/ss_thumbnails/enrecommendationsforhealthcareprofessionals1-220805065208-e2a09f46-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Thalassaemia from ‘A’ to ‘Z’: A Comprehensive e-Glossary for Patients with Thalassaemia /slideshow/thalassaemia-from-a-to-z-a-comprehensive-eglossary-for-patients-with-thalassaemia/250469108 thalassaemiafromatozacomprehensivee-glossaryforthalassaemia-211018122356
The “Thalassaemia from A to Z” electronic glossary is a comprehensive, easy-to-use, educational tool for thalassaemia, including definitions of all important concepts on the prevention, management, treatment, organ complications, and plenty of other aspects related to the disease. - English -]]>
The “Thalassaemia from A to Z” electronic glossary is a comprehensive, easy-to-use, educational tool for thalassaemia, including definitions of all important concepts on the prevention, management, treatment, organ complications, and plenty of other aspects related to the disease. - English -]]> Mon, 18 Oct 2021 12:23:56 GMT /slideshow/thalassaemia-from-a-to-z-a-comprehensive-eglossary-for-patients-with-thalassaemia/250469108 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Thalassaemia from ‘A’ to ‘Z’: A Comprehensive e-Glossary for Patients with Thalassaemia ThalassaemiaInternat The “Thalassaemia from A to Z” electronic glossary is a comprehensive, easy-to-use, educational tool for thalassaemia, including definitions of all important concepts on the prevention, management, treatment, organ complications, and plenty of other aspects related to the disease. - English - <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/thalassaemiafromatozacomprehensivee-glossaryforthalassaemia-211018122356-thumbnail.jpg?width=120&height=120&fit=bounds" /> The “Thalassaemia from A to Z” electronic glossary is a comprehensive, easy-to-use, educational tool for thalassaemia, including definitions of all important concepts on the prevention, management, treatment, organ complications, and plenty of other aspects related to the disease. - English -

Thalassaemia from ‘A’ to ‘Z’: A Comprehensive e-Glossary for Patients with Thalassaemia from Thalassaemia International Federation

]]> 73 0 https://cdn.slidesharecdn.com/ss_thumbnails/thalassaemiafromatozacomprehensivee-glossaryforthalassaemia-211018122356-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 COVID-19 Developing Vaccinations & Therapeutic Drugs (Update: 15 October 2021) /slideshow/covid19-developing-vaccinations-therapeutic-drugs-update-15-october-2021/250468977 211015-covid-19-vaccines-updatefinal-211018120635
Here's exactly where we're at with vaccines and #reatments for COVID-19! In this newly published issue of TIF's ''COVID-19 Vaccinations & Therapeutic Drugs'' Guide, you can find out the latest on the current status of COVID-19 vaccinations across the world, the new vaccines and promising treatments, such as molnupiravir, and much more.]]>
Here's exactly where we're at with vaccines and #reatments for COVID-19! In this newly published issue of TIF's ''COVID-19 Vaccinations & Therapeutic Drugs'' Guide, you can find out the latest on the current status of COVID-19 vaccinations across the world, the new vaccines and promising treatments, such as molnupiravir, and much more.]]> Mon, 18 Oct 2021 12:06:35 GMT /slideshow/covid19-developing-vaccinations-therapeutic-drugs-update-15-october-2021/250468977 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) COVID-19 Developing Vaccinations & Therapeutic Drugs (Update: 15 October 2021) ThalassaemiaInternat Here's exactly where we're at with vaccines and #reatments for COVID-19! In this newly published issue of TIF's ''COVID-19 Vaccinations & Therapeutic Drugs'' Guide, you can find out the latest on the current status of COVID-19 vaccinations across the world, the new vaccines and promising treatments, such as molnupiravir, and much more. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/211015-covid-19-vaccines-updatefinal-211018120635-thumbnail.jpg?width=120&height=120&fit=bounds" /> Here's exactly where we're at with vaccines and #reatments for COVID-19! In this newly published issue of TIF's ''COVID-19 Vaccinations & Therapeutic Drugs'' Guide, you can find out the latest on the current status of COVID-19 vaccinations across the world, the new vaccines and promising treatments, such as molnupiravir, and much more.

COVID-19 Developing Vaccinations & Therapeutic Drugs (Update: 15 October 2021) from Thalassaemia International Federation

]]> 112 0 https://cdn.slidesharecdn.com/ss_thumbnails/211015-covid-19-vaccines-updatefinal-211018120635-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021) /ThalassaemiaInternat/guidelines-for-the-management-of-transfusion-dependent-thalassaemia-4th-edition-2021-249616429 finalguideline4th-210706061934
TIF, its Board of Directors, and its International Scientific Advisory Board proudly present the 4th Edition of the Federation’s most prestigious and renowned publication, the TIF Guidelines For The Management of Transfusion-Dependent Thalassaemia (TDT). Since 1999, when the very first edition was originally released as part of the Federation’s Educational Programme, the TIF Guidelines have been adopted and used extensively by academics, researchers and healthcare professionals all over the world as the only evidence-based reference text concerning the treatment of patients with TDT. The newly launched edition includes brand new chapters on the recently approved modalities of patient treatment, the value of patient engagement at the decision-making level, the Reference Centres’ contribution to patient care, and much more. ]]>
TIF, its Board of Directors, and its International Scientific Advisory Board proudly present the 4th Edition of the Federation’s most prestigious and renowned publication, the TIF Guidelines For The Management of Transfusion-Dependent Thalassaemia (TDT). Since 1999, when the very first edition was originally released as part of the Federation’s Educational Programme, the TIF Guidelines have been adopted and used extensively by academics, researchers and healthcare professionals all over the world as the only evidence-based reference text concerning the treatment of patients with TDT. The newly launched edition includes brand new chapters on the recently approved modalities of patient treatment, the value of patient engagement at the decision-making level, the Reference Centres’ contribution to patient care, and much more. ]]> Tue, 06 Jul 2021 06:19:33 GMT /ThalassaemiaInternat/guidelines-for-the-management-of-transfusion-dependent-thalassaemia-4th-edition-2021-249616429 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021) ThalassaemiaInternat TIF, its Board of Directors, and its International Scientific Advisory Board proudly present the 4th Edition of the Federation’s most prestigious and renowned publication, the TIF Guidelines For The Management of Transfusion-Dependent Thalassaemia (TDT). Since 1999, when the very first edition was originally released as part of the Federation’s Educational Programme, the TIF Guidelines have been adopted and used extensively by academics, researchers and healthcare professionals all over the world as the only evidence-based reference text concerning the treatment of patients with TDT. The newly launched edition includes brand new chapters on the recently approved modalities of patient treatment, the value of patient engagement at the decision-making level, the Reference Centres’ contribution to patient care, and much more. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/finalguideline4th-210706061934-thumbnail.jpg?width=120&height=120&fit=bounds" /> TIF, its Board of Directors, and its International Scientific Advisory Board proudly present the 4th Edition of the Federation’s most prestigious and renowned publication, the TIF Guidelines For The Management of Transfusion-Dependent Thalassaemia (TDT). Since 1999, when the very first edition was originally released as part of the Federation’s Educational Programme, the TIF Guidelines have been adopted and used extensively by academics, researchers and healthcare professionals all over the world as the only evidence-based reference text concerning the treatment of patients with TDT. The newly launched edition includes brand new chapters on the recently approved modalities of patient treatment, the value of patient engagement at the decision-making level, the Reference Centres’ contribution to patient care, and much more.

Guidelines for the Management of Transfusion Dependent Thalassaemia (4th Edition – 2021) from Thalassaemia International Federation

]]> 431 0 https://cdn.slidesharecdn.com/ss_thumbnails/finalguideline4th-210706061934-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 A Guide for the Haemoglobinopathy Nurse (2013) /slideshow/a-guide-for-the-haemoglobinopathy-nurse-2013/248348581 nursesguideenglish-210519063407
Nurses play a critical role in any team of healthcare professionals involved in the care of patients with chronic diseases, including Hb disorders such as thalassaemia and sickle dell disease. These are extremely challenging diseases that are fatal if left untreated. However, by sharing expert knowledge on their prevention and treatment, these conditions can be effectively managed. TIF places great importance on nursing as a valued part of patient care well beyond the medical component. We hope that this Guide will help and motivate more nurses across the world to become involved in the care of patients with this group of diseases. ]]>
Nurses play a critical role in any team of healthcare professionals involved in the care of patients with chronic diseases, including Hb disorders such as thalassaemia and sickle dell disease. These are extremely challenging diseases that are fatal if left untreated. However, by sharing expert knowledge on their prevention and treatment, these conditions can be effectively managed. TIF places great importance on nursing as a valued part of patient care well beyond the medical component. We hope that this Guide will help and motivate more nurses across the world to become involved in the care of patients with this group of diseases. ]]> Wed, 19 May 2021 06:34:07 GMT /slideshow/a-guide-for-the-haemoglobinopathy-nurse-2013/248348581 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) A Guide for the Haemoglobinopathy Nurse (2013) ThalassaemiaInternat Nurses play a critical role in any team of healthcare professionals involved in the care of patients with chronic diseases, including Hb disorders such as thalassaemia and sickle dell disease. These are extremely challenging diseases that are fatal if left untreated. However, by sharing expert knowledge on their prevention and treatment, these conditions can be effectively managed. TIF places great importance on nursing as a valued part of patient care well beyond the medical component. We hope that this Guide will help and motivate more nurses across the world to become involved in the care of patients with this group of diseases. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nursesguideenglish-210519063407-thumbnail.jpg?width=120&height=120&fit=bounds" /> Nurses play a critical role in any team of healthcare professionals involved in the care of patients with chronic diseases, including Hb disorders such as thalassaemia and sickle dell disease. These are extremely challenging diseases that are fatal if left untreated. However, by sharing expert knowledge on their prevention and treatment, these conditions can be effectively managed. TIF places great importance on nursing as a valued part of patient care well beyond the medical component. We hope that this Guide will help and motivate more nurses across the world to become involved in the care of patients with this group of diseases.

A Guide for the Haemoglobinopathy Nurse (2013) from Thalassaemia International Federation

]]> 120 0 https://cdn.slidesharecdn.com/ss_thumbnails/nursesguideenglish-210519063407-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 TIF Global Thalassaemia Review 2021 /slideshow/tif-global-thalassaemia-review-2021-248348556/248348556 globalthalassaemiareviewtest-210519062855
The Global Thalassaemia Review 2021 (GTR) constitutes perhaps the most comprehensive work of the last decade on thalassaemia. Comprising of almost 500 pages, the real face of thalassaemia will be revealed to the reader demonstrating the immense disease burden that falls on the shoulders of thousands of thalassaemia patients and their families in their struggle to access quality healthcare services that will enable their survival. ]]>
The Global Thalassaemia Review 2021 (GTR) constitutes perhaps the most comprehensive work of the last decade on thalassaemia. Comprising of almost 500 pages, the real face of thalassaemia will be revealed to the reader demonstrating the immense disease burden that falls on the shoulders of thousands of thalassaemia patients and their families in their struggle to access quality healthcare services that will enable their survival. ]]> Wed, 19 May 2021 06:28:54 GMT /slideshow/tif-global-thalassaemia-review-2021-248348556/248348556 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) TIF Global Thalassaemia Review 2021 ThalassaemiaInternat The Global Thalassaemia Review 2021 (GTR) constitutes perhaps the most comprehensive work of the last decade on thalassaemia. Comprising of almost 500 pages, the real face of thalassaemia will be revealed to the reader demonstrating the immense disease burden that falls on the shoulders of thousands of thalassaemia patients and their families in their struggle to access quality healthcare services that will enable their survival. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/globalthalassaemiareviewtest-210519062855-thumbnail.jpg?width=120&height=120&fit=bounds" /> The Global Thalassaemia Review 2021 (GTR) constitutes perhaps the most comprehensive work of the last decade on thalassaemia. Comprising of almost 500 pages, the real face of thalassaemia will be revealed to the reader demonstrating the immense disease burden that falls on the shoulders of thousands of thalassaemia patients and their families in their struggle to access quality healthcare services that will enable their survival.

TIF Global Thalassaemia Review 2021 from Thalassaemia International Federation

]]> 500 0 https://cdn.slidesharecdn.com/ss_thumbnails/globalthalassaemiareviewtest-210519062855-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Guidelines for the Management of Non-Transfusion-Dependent Thalassaemia (NTDT) - 2nd Edition (2017) /slideshow/guidelines-for-the-management-of-nontransfusiondependent-thalassaemia-ntdt-2nd-edition-2017/248344015 ntdt-final-combined-1-210518130419
In these updated guidelines, we feature the most prominent pathophysiologic mechanisms and clinical morbidities commonly encountered in NTDT patients, and provide practical recommendations for combating these morbidities. Our recommendations stem from the most recent evidence delivered through published observational studies or clinical trials. In areas where evidence is unavailable or insufficient, the editors provide, through consensus, management recommendations using their clinical expertise in treating NTDT patients. ]]>
In these updated guidelines, we feature the most prominent pathophysiologic mechanisms and clinical morbidities commonly encountered in NTDT patients, and provide practical recommendations for combating these morbidities. Our recommendations stem from the most recent evidence delivered through published observational studies or clinical trials. In areas where evidence is unavailable or insufficient, the editors provide, through consensus, management recommendations using their clinical expertise in treating NTDT patients. ]]> Tue, 18 May 2021 13:04:19 GMT /slideshow/guidelines-for-the-management-of-nontransfusiondependent-thalassaemia-ntdt-2nd-edition-2017/248344015 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Guidelines for the Management of Non-Transfusion-Dependent Thalassaemia (NTDT) - 2nd Edition (2017) ThalassaemiaInternat In these updated guidelines, we feature the most prominent pathophysiologic mechanisms and clinical morbidities commonly encountered in NTDT patients, and provide practical recommendations for combating these morbidities. Our recommendations stem from the most recent evidence delivered through published observational studies or clinical trials. In areas where evidence is unavailable or insufficient, the editors provide, through consensus, management recommendations using their clinical expertise in treating NTDT patients. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ntdt-final-combined-1-210518130419-thumbnail.jpg?width=120&height=120&fit=bounds" /> In these updated guidelines, we feature the most prominent pathophysiologic mechanisms and clinical morbidities commonly encountered in NTDT patients, and provide practical recommendations for combating these morbidities. Our recommendations stem from the most recent evidence delivered through published observational studies or clinical trials. In areas where evidence is unavailable or insufficient, the editors provide, through consensus, management recommendations using their clinical expertise in treating NTDT patients.

Guidelines for the Management of Non-Transfusion-Dependent Thalassaemia (NTDT) - 2nd Edition (2017) from Thalassaemia International Federation

]]> 213 0 https://cdn.slidesharecdn.com/ss_thumbnails/ntdt-final-combined-1-210518130419-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Prevention and Diagnosis of Haemoglobinopathies - A Short Guide for Health Professionals and Laboratory Scientists (2016) /slideshow/prevention-and-diagnosis-of-haemoglobinopathies-a-short-guide-for-health-professionals-and-laboratory-scientists-2016/248343926 preventiondiagnosis-of-hbpathiesbookletnew-1-210518125334
This booklet on the prevention and diagnosis of the haemoglobinopathies is intended to be a reference booklet serving as a short guide directed towards health professionals and laboratory scientists undertaking haematological screening and molecular diagnosis of the thalassaemias and other haemoglobin disorders.]]>
This booklet on the prevention and diagnosis of the haemoglobinopathies is intended to be a reference booklet serving as a short guide directed towards health professionals and laboratory scientists undertaking haematological screening and molecular diagnosis of the thalassaemias and other haemoglobin disorders.]]> Tue, 18 May 2021 12:53:34 GMT /slideshow/prevention-and-diagnosis-of-haemoglobinopathies-a-short-guide-for-health-professionals-and-laboratory-scientists-2016/248343926 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Prevention and Diagnosis of Haemoglobinopathies - A Short Guide for Health Professionals and Laboratory Scientists (2016) ThalassaemiaInternat This booklet on the prevention and diagnosis of the haemoglobinopathies is intended to be a reference booklet serving as a short guide directed towards health professionals and laboratory scientists undertaking haematological screening and molecular diagnosis of the thalassaemias and other haemoglobin disorders. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/preventiondiagnosis-of-hbpathiesbookletnew-1-210518125334-thumbnail.jpg?width=120&height=120&fit=bounds" /> This booklet on the prevention and diagnosis of the haemoglobinopathies is intended to be a reference booklet serving as a short guide directed towards health professionals and laboratory scientists undertaking haematological screening and molecular diagnosis of the thalassaemias and other haemoglobin disorders.

Prevention and Diagnosis of Haemoglobinopathies - A Short Guide for Health Professionals and Laboratory Scientists (2016) from Thalassaemia International Federation

]]> 71 0 https://cdn.slidesharecdn.com/ss_thumbnails/preventiondiagnosis-of-hbpathiesbookletnew-1-210518125334-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Bone Marrow Transplantation (BMS) in β-Thalassaemia (2018) /slideshow/bone-marrow-transplantation-bms-in-thalassaemia/248343884 tif-bmt-v4final-210518124933
An educational leaflet by the Thalassaemia International Federation (TIF) with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).]]>
An educational leaflet by the Thalassaemia International Federation (TIF) with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).]]> Tue, 18 May 2021 12:49:33 GMT /slideshow/bone-marrow-transplantation-bms-in-thalassaemia/248343884 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Bone Marrow Transplantation (BMS) in β-Thalassaemia (2018) ThalassaemiaInternat An educational leaflet by the Thalassaemia International Federation (TIF) with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT). <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tif-bmt-v4final-210518124933-thumbnail.jpg?width=120&height=120&fit=bounds" /> An educational leaflet by the Thalassaemia International Federation (TIF) with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).

Bone Marrow Transplantation (BMS) in 硫-Thalassaemia (2018) from Thalassaemia International Federation

]]> 43 0 https://cdn.slidesharecdn.com/ss_thumbnails/tif-bmt-v4final-210518124933-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 A Short Guide for the Management of Transfusion Dependent Thalassaemia (2017) /slideshow/a-short-guide-for-the-management-of-transfusion-dependent-thalassaemia-2017/248343810 short-guide-low-res-210518124300
By providing a short pocket guide describing the best possible practices in the treatment and management of Transfusion Dependent Thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. This effort is also supported in TIF’s educational programme, aiming to ensure that physicians and other healthcare professionals have all the necessary knowledge to support their patients. ]]>
By providing a short pocket guide describing the best possible practices in the treatment and management of Transfusion Dependent Thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. This effort is also supported in TIF’s educational programme, aiming to ensure that physicians and other healthcare professionals have all the necessary knowledge to support their patients. ]]> Tue, 18 May 2021 12:42:59 GMT /slideshow/a-short-guide-for-the-management-of-transfusion-dependent-thalassaemia-2017/248343810 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) A Short Guide for the Management of Transfusion Dependent Thalassaemia (2017) ThalassaemiaInternat By providing a short pocket guide describing the best possible practices in the treatment and management of Transfusion Dependent Thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. This effort is also supported in TIF’s educational programme, aiming to ensure that physicians and other healthcare professionals have all the necessary knowledge to support their patients. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/short-guide-low-res-210518124300-thumbnail.jpg?width=120&height=120&fit=bounds" /> By providing a short pocket guide describing the best possible practices in the treatment and management of Transfusion Dependent Thalassaemia (TDT), TIF seeks to support physicians worldwide in making good clinical decisions that can benefit individual patients and enable them to advocate for more and better resources for thalassaemia care at the level of national health authorities. This effort is also supported in TIF’s educational programme, aiming to ensure that physicians and other healthcare professionals have all the necessary knowledge to support their patients.

A Short Guide for the Management of Transfusion Dependent Thalassaemia (2017) from Thalassaemia International Federation

]]> 65 0 https://cdn.slidesharecdn.com/ss_thumbnails/short-guide-low-res-210518124300-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Gene Therapy in β-Thalassaemia & other Haemoglobin Disorders (2019) /slideshow/gene-therapy-in-thalassaemia-other-haemoglobin-disorders/248343791 tif-gene-therapyfinal-210518123804
An educational leaflet aiming to strengthen the knowledge and understanding of patients with thalassaemia and other haemoglobin disorders across the world on most aspects relevant to gene therapy.]]>
An educational leaflet aiming to strengthen the knowledge and understanding of patients with thalassaemia and other haemoglobin disorders across the world on most aspects relevant to gene therapy.]]> Tue, 18 May 2021 12:38:04 GMT /slideshow/gene-therapy-in-thalassaemia-other-haemoglobin-disorders/248343791 ThalassaemiaInternat@slideshare.net(ThalassaemiaInternat) Gene Therapy in β-Thalassaemia & other Haemoglobin Disorders (2019) ThalassaemiaInternat An educational leaflet aiming to strengthen the knowledge and understanding of patients with thalassaemia and other haemoglobin disorders across the world on most aspects relevant to gene therapy. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tif-gene-therapyfinal-210518123804-thumbnail.jpg?width=120&height=120&fit=bounds" /> An educational leaflet aiming to strengthen the knowledge and understanding of patients with thalassaemia and other haemoglobin disorders across the world on most aspects relevant to gene therapy.

Gene Therapy in 硫-Thalassaemia & other Haemoglobin Disorders (2019) from Thalassaemia International Federation

]]> 82 0 https://cdn.slidesharecdn.com/ss_thumbnails/tif-gene-therapyfinal-210518123804-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-ThalassaemiaInternat-48x48.jpg?cb=1673441180 https://cdn.slidesharecdn.com/ss_thumbnails/tdt-guide-2022-for-web-220805065703-248e232b-thumbnail.jpg?width=320&height=320&fit=bounds ThalassaemiaInternat/short-guide-for-the-management-of-transfusiondependent-thalassaemia-2nd-edition-2022 Short Guide For the Ma... https://cdn.slidesharecdn.com/ss_thumbnails/enrecommendationsforhealthcareprofessionals1-220805065208-e2a09f46-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/basic-recommendations-in-brief-for-treating-physicians-2022/252436895 Basic Recommendations ... https://cdn.slidesharecdn.com/ss_thumbnails/thalassaemiafromatozacomprehensivee-glossaryforthalassaemia-211018122356-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/thalassaemia-from-a-to-z-a-comprehensive-eglossary-for-patients-with-thalassaemia/250469108 Thalassaemia from ‘A’ ...